| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.026 | 0.9 |